Warfarin Current Events | Warfarin News | 2
|
|
|
Sort By:
Page Views | Date |
New blood thinner studied for patients with leg and lung clots
A new oral blood thinner is being compared to an old standby to see if it works as well and is easier to manage long term, researchers say. view more (2007-02-13)
Genetic information personalizes warfarin prescribing
Warfarin, one of the world's most widely used drugs, is also one of the trickiest to prescribe. Half of those who take it are at risk of serious problems when given the standard starting dose. view more (2009-02-19)
Mutant rats offer clues to medical mystery
A research project at Rice University has brought scientists to the brink of comprehending a long-standing medical mystery that may link cardiovascular disease, osteoporosis and perhaps even Alzheimer's disease. view more (2009-02-18)
Cholesterol-lowering Drug May Also Reduce Risk of Blood Clots
Statin drugs, commonly used to lower high cholesterol blood levels, have been shown to possibly decrease the risk for thrombotic complications of antiphospholipid syndrome (APS), a disease associated with blood clotting and recurrent fetal loss. Research conducted on animal models, has shown success in using the drug fluvastatin to inhibit the... view more... (2004-11-10)
ESC Congress 2004: Efficacy and safety of ximelagatran confirmed for stroke prevention in atrial fibrillation
European Society of Cardiology Congress (ESC), Munich, Germany: Results presented today from the final pooled analysis of SPORTIF III and V1,2 confirm that ximelagatran - the first oral direct thrombin inhibitor (oral DTI) - is as effective as well-controlled warfarin, the current standard anticoagulant treatment for the prevention of stroke in... view more... (2004-08-29)
Penn study identifies patients most at-risk for secondary strokes
Among patients who have suffered a single stroke, researchers at the University of Pennsylvania School of Medicine, along with colleagues at other institutions, have found that severe stenosis, or narrowing, of the arteries in the head represents a major risk factor for the development of a subsequent stroke. view more (2006-01-30)
NIH report on intracranial stent points out need for upcoming large-scale clinical trial
A preliminary study funded by the National Institutes of Health found that a stent designed to open clogged arteries in the brain was successfully deployed in nearly all cases and significantly reduced arterial blockage in the short term. But data on the long-term benefit of the stent, compared to medical treatment alone, were inconclusive,... view more... (2008-02-14)
Many oncologists unaware of cancer clot risk
Patients receiving cancer treatments are at greater risk of blood clots, yet more than a quarter of oncologists do not recognise their clotting effects and preventive measures are rarely used, finds a study in this week’s BMJ. view more (2003-09-10)
Professor Tom Meade Wins The Second MRC Millennium Medal For Outstanding Contribution To Uk Health
Professor Tom Meade, epidemiologist, visionary researcher and clinician, will be awarded the Medical Research Council's second Millennium Medal for outstanding contribution to UK health this evening (Tuesday 23 July 2002). Professor Meade's work on coagulation overturned conventional wisdom about the systems in the body which contribute to... view more... (2002-07-23)
More patients needed in clinical trials to find treatment for heart condition linked to certain strokes
The American Heart Association and the American College of Cardiology are calling on doctors to enroll more patients in clinical trials for catheter-based closure of patent foramen ovale (PFO), a condition caused when an opening between the two chambers of the heart fails to close at birth. view more (2009-05-12)
The Biochemist February 2002 issue; THEME: Pretty poisonous
Introduction - The darker end of the spectrum The 'pretty poisonous' entities that are the subject of this issue of The Biochemist have a much darker side - they might be subject to misuse by those with malevolent intent. Toxins and bioregulators have certainly been considered and developed as weapons by some. In the late 20th Century,... view more... (2002-02-11)
Women may stop anticoagulants after blood clots
Women may safely discontinue oral anticoagulants (blood thinners) after 6 months of treatment following a first unprovoked venous blood clot (thromboembolism) if they have no or one risk factor. view more (2008-08-26)
ESF study helps stop drugs slipping through safety net
Recent advances in genetic screening will lead to safer pharmaceutical drugs, with reduced adverse side effects, if the methods are incorporated in clinical development. view more (2008-09-17)
Research highlights new approaches to prevent blood clots
Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. view more (2008-12-08)
Study Finds Half of Patients Undergoing Cerebrovascular Stent Placement Respond Poorly to the Antiplatelet Drug Clopidogrel (Plavix)
A study by researchers at Rush University Medical Center, published in the February issue of the American Journal of Neuroradiology, finds that half of patients undergoing cerebrovascular stent placement did not respond well to clopidogrel. Clopidogrel (Plavix) and aspirin are medications routinely prescribed for 1-3 months following... view more... (2008-02-06)
Less expensive anti-clotting medication appears as safe and effective as more expensive treatment
Subcutaneous (beneath the skin) injection of the original and less expensive form of the anticoagulant medication heparin is as effective and safe as subcutaneous administration of the newer and more expensive low-molecular-weight heparin for treatment of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs). view more (2006-08-23)
Blood clots can be treated by injections at home
Treatment of blood clots in the deep veins of the legs or the lungs with an older, less expensive form of the anticoagulant medication heparin can be just as safe and effective as similar treatment with a newer and more expensive heparin. view more (2006-08-23)
Are blood thinners post-op killers?
New study shows that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths after surgery view more (2008-04-01)
NEW SYNTHETIC ANTITHROMBOTIC DRUG COULD REDUCE DVT RISK AFTER HIP SURGERY (pp 1710, 1715, 1721)
Two studies in this week's issue of THE LANCET highlight how a new class of synthetic antithrombotic drug could be more effective than conventional therapy in reducing the risk of potentially fatal blood clots associated with hip-replacement surgery. Between 16 and 30% of patients who undergo Hip-replacement surgery have a risk... view more... (2002-05-15)
Monash researchers lead the way in blood clotting discovery
A Monash-led research team has discovered an entirely new mechanism that promotes blood clot formation - a major breakthrough that will impact on treatment and prevention of heart disease and stroke. view more (2009-05-26)
|
|
|
|
Sort By:
Page Views | Date |
|
